Frontiers in Oncology | Breast Cancer

Original Research

Published on 21 Aug 2023

Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period

in Breast Cancer

Mao Ding
Hongyu Xiang
Jingming Ye
Yuanjia Cheng
Qian Liu
Ling Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1203119

1,423 views

Original Research

Published on 18 Aug 2023

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

in Breast Cancer

Danfeng Zhang
Man Wang
Xufeng Huang
Longbin Wang
Ying Liu
Shujing Zhou
Yidan Tang
Qi Wang
Zhengrui Li
Geng Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1220038

2,639 views
3 citations

Original Research

Published on 17 Aug 2023

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study

in Breast Cancer

Jiajie Shi
Liqiu Zhang
Cuizhi Geng

Frontiers in Oncology

doi 10.3389/fonc.2023.1210314

2,854 views
1 citation

Original Research

Published on 17 Aug 2023

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

in Breast Cancer

Yomali Ferreyra
Gina Rosas
Alicia M. Cock-Rada
Jhajaira Araujo
Leny Bravo
Franco Doimi
Jhoysi Casas
María de los Ángeles Clavo
Joseph A. Pinto
Carolina Belmar-López

Frontiers in Oncology

doi 10.3389/fonc.2023.1227864

4,919 views
4 citations

Review

Published on 17 Aug 2023

Elucidating the roles of the mammary and gut microbiomes in breast cancer development

in Breast Cancer

Courtney Hoskinson
Rachel Yutong Jiang
Leah T. Stiemsma

Frontiers in Oncology

doi 10.3389/fonc.2023.1198259

3,510 views
4 citations

Original Research

Published on 16 Aug 2023

Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer

in Breast Cancer

Fei Xu
Dan Ou
Weixiang Qi
Shubei Wang
Yiming Han
Gang Cai
Lu Cao
Cheng Xu
Jia-Yi Chen

Frontiers in Oncology

doi 10.3389/fonc.2023.1160802

1,470 views

Systematic Review

Published on 16 Aug 2023

Predictive value of radiomics-based machine learning for the disease-free survival in breast cancer: a systematic review and meta-analysis

in Breast Cancer

Dongmei Lu
Yuke Yan
Min Jiang
Shaoqin Sun
Haifeng Jiang
Yashan Lu
Wenwen Zhang
Xing Zhou

Frontiers in Oncology

doi 10.3389/fonc.2023.1173090

2,200 views
3 citations

Original Research

Published on 15 Aug 2023

Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis

in Breast Cancer

Ta-Chung Chao
Yi-Fang Tsai
Chun-Yu Liu
Pei-Ju Lien
Yen-Shu Lin
Chin-Jung Feng
Yen-Jen Chen
Jiun-I. Lai
Chih-Yi Hsu
Jiun Jen Lynn

Frontiers in Oncology

doi 10.3389/fonc.2023.1192946

2,601 views
3 citations

Original Research

Published on 15 Aug 2023

Evaluating the expression of heat shock protein 27 and topoisomerase II α in a retrospective cohort of patients diagnosed with locally advanced breast cancer and treated with neoadjuvant anthracycline-based chemotherapies

in Breast Cancer

Yixuan Zhuang
Fan Zhang
Yue Xu
Lifang He
Wenhe Huang
Chaoqun Hong
Yukun Cui

Frontiers in Oncology

doi 10.3389/fonc.2023.1067179

1,448 views
2 citations

Original Research

Published on 11 Aug 2023

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer

in Breast Cancer

Sarah Sammons
Andrew Elliott
Romualdo Barroso-Sousa
Saranya Chumsri
Antoinette R. Tan
George W. Sledge
Sara M. Tolaney
Evanthia T. Roussos Torres

Frontiers in Oncology

doi 10.3389/fonc.2023.1235902

4,179 views
3 citations

Original Research

Published on 11 Aug 2023

Improved awareness of physical activities is associated with a gain of fitness and a stable body weight in breast cancer patients during the first year of antineoplastic therapy: the BEGYN-1 study

in Breast Cancer

Cosima Zemlin
Julia Theresa Schleicher
Laura Altmayer
Caroline Stuhlert
Carolin Wörmann
Marina Lang
Laura-Sophie Scherer
Ida Clara Thul
Lisanne Sophie Spenner
Jana Alisa Simon

Frontiers in Oncology

doi 10.3389/fonc.2023.1198157

1,856 views
1 citation

Original Research

Published on 11 Aug 2023

Clinical implications and immune implications features of TARS1 in breast cancer

in Breast Cancer

Zhengwei Gui
Piao Liu
Dong Zhang
Wanju Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1207867

1,851 views
3 citations

Systematic Review

Published on 11 Aug 2023

An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis

in Breast Cancer

Usman Ayub Awan
Aamer Ali Khattak
Noman Ahmed
Xingyi Guo
Sohail Akhtar
Shehrish Kamran
Zhao Yongjing
Jianbo Liu
Suliman Khan

Frontiers in Oncology

doi 10.3389/fonc.2023.1219161

3,712 views
7 citations

Original Research

Published on 09 Aug 2023

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer

in Breast Cancer

Lanqi Ren
Ning Ren
Yu Zheng
Yibei Yang
Qiaoping Xu

Frontiers in Oncology

doi 10.3389/fonc.2023.1221969

1,864 views
1 citation

Study Protocol

Published on 09 Aug 2023

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

in Breast Cancer

Amparo Garcia-Tejedor
Carlos Ortega-Exposito
Sira Salinas
Ana Luzardo-González
Catalina Falo
Evelyn Martinez-Pérez
Héctor Pérez-Montero
M. Teresa Soler-Monsó
Maria-Teresa Bajen
Ana Benitez

Frontiers in Oncology

doi 10.3389/fonc.2023.1184021

10,390 views
11 citations

Original Research

Published on 08 Aug 2023

Exploring autonomic modulation: day-to-day recovery after exercise sessions in breast cancer survivors

in Breast Cancer

Ana Myriam Lavín-Pérez
Daniel Collado-Mateo
Carmen Hinojo González
Ana de Juan Ferré
Cristina Ruisánchez Villar
Xián Mayo
Alfonso Jiménez

Frontiers in Oncology

doi 10.3389/fonc.2023.1231683

1,808 views

Navigation group

Articles

Comparison of adverse effects of anti-tumor therapy for breast cancer shortly after COVID-19 diagnosis vs. the control period

GLS as a diagnostic biomarker in breast cancer: in-silico, in-situ, and in-vitro insights

HER-2 ultra-low breast cancer: exploring the clinicopathological features and prognosis in a retrospective study

Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

Elucidating the roles of the mammary and gut microbiomes in breast cancer development

Impact of multidisciplinary team on the pattern of care for brain metastasis from breast cancer

Predictive value of radiomics-based machine learning for the disease-free survival in breast cancer: a systematic review and meta-analysis

Prevalence of PIK3CA mutations in Taiwanese patients with breast cancer: a retrospective next-generation sequencing database analysis

Evaluating the expression of heat shock protein 27 and topoisomerase II α in a retrospective cohort of patients diagnosed with locally advanced breast cancer and treated with neoadjuvant anthracycline-based chemotherapies

Concurrent predictors of an immune responsive tumor microenvironment within tumor mutational burden-high breast cancer

Improved awareness of physical activities is associated with a gain of fitness and a stable body weight in breast cancer patients during the first year of antineoplastic therapy: the BEGYN-1 study

Clinical implications and immune implications features of TARS1 in breast cancer

An updated systemic review and meta-analysis on human papillomavirus in breast carcinogenesis

Economic evaluation of third-line neratinib plus capecitabine versus lapatinib plus capecitabine with HER2+ metastatic breast cancer

Axillary lymph node dissection versus radiotherapy in breast cancer with positive sentinel nodes after neoadjuvant therapy (ADARNAT trial)

Exploring autonomic modulation: day-to-day recovery after exercise sessions in breast cancer survivors